Adiponectin, resistin, Interleukine-4, TGF-β2 levels before and after clozapine treatment in a group of first episode, treatment resistant schizophrenia patients

INTRODUCTION: Treatment resistant schizophrenia (TRS) affects at least 15-20% of newly diagnosed patients with schizophrenia. Clozapine treatment for this sub-group of patients should be considered immediately after the failure in response to two antipsychotics (usually risperidone and olanzapine) r...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrikis, P., Karampas, A., Leondaritis, G., Archimandriti, D., Spyrou, P., Plakoutsis, M., Georgiou, G., Mantas, C., Voulgari, P., Hyphantis, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661383/
http://dx.doi.org/10.1192/j.eurpsy.2023.1326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661383/
http://dx.doi.org/10.1192/j.eurpsy.2023.1326

Ejemplares similares